Filing Details
- Accession Number:
- 0001209191-19-008675
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 17:27:41
- Reporting Period:
- 2019-02-06
- Accepted Time:
- 2019-02-08 17:27:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1377121 | Protagonist Therapeutics Inc | PTGX | Pharmaceutical Preparations (2834) | 980505495 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1675878 | S. Richard Shames | C/O Protagonist Therapeutics, Inc. 7707 Gateway Boulevard, Suite 140 Newark CA 94560 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-06 | 198 | $8.15 | 26,758 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-06 | 2,580 | $7.71 | 24,178 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.